Advanced Telemonitoring of Patients With Heart Failure in Home Environment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-11-11

Study Completion Date

2023-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Heart failure is currently not only a major medical but also a socio-economic problem. Its prevalence is estimated at 1-2% of the population with an exponential increase in older age groups. A very important part of the treatment of heart failure is the gradual uptitration of therapy to the maximum tolerated doses. Properly conducted therapy titration requires more frequent patient contact. Thanks to the introduction of telemedicine techniques, the investigators can communicate more effectively with the patient, reach the target doses of heart failure medication faster and subsequently reduce the number of hospitalizations due to worsening of heart failure.

This study investigates effect of advanced telemonitoring of patients with heart failure in home environment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Patient-centred Home-based Management of Heart Failure

NCT03655496

Heart Failure

COMPLETED PHASE1

Telemedicine in Heart Failure; Treatment, Prognosis and Patient Experience

NCT06237998

Heart Failure

COMPLETED

Heart Failure Patient Management and Interventions Using Continuous Patient Monitoring Outside Hospitals and Real-world Data

NCT07008729

Chronic Heart Failure Heart Transplant Recipient Left Ventricular Assist Device

ACTIVE_NOT_RECRUITING NA

AI-Based Monitoring System for Chronic Heart Failure With Advanced Wearable and Mini-Invasive Devices

NCT06909682

Chronic Heart Failure Cardiovascular Diseases Heart Failure With Reduced Ejection Fraction (HFrEF) +2 more

NOT_YET_RECRUITING

Effectiveness of a Cardiac Telerehabilitation Program in Chronic Heart Failure

NCT07023536

Heart Failure

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Medimonitor

A digital solution consisting of smartphone/tablet based application gathering data from medical and other devices provided to the patients. These devices are as follows: tablet, smartwatch, mobile ECG, blood pressure monitor, weight scales, pulse oximetry device.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* LVEF ≤ 40%
* exclusion of obstructive coronary artery disease
* NTproBNP ≥ 125pg/ml
* ≥ 60 years of age
* Informed written and verbal consent
* Able to participate in study activities

Exclusion Criteria

* LVEF ≥ 40%
* Ischaemic ethiology of cardiomyopathy
* NTproBNP ≤ 125pg/ml
* Severe psychological disturbances
* Absence of collaboration (informed consent)
* BP ≤ 110mmHg without hypertensive medication

Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No